Phase IGLP-1
Compound 61482
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061482
Risk Class
MODERATE
Last Audit
Mar 2, 2108
Research Abstract
GLP-1 candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 61482 is a glp-1 asset inside glp-1 innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in phase i with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061482 with updates logged 2108-03-02.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-61482GLP-1 Program 61482
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061482
- [2] Operations Pulse • GLP-1 innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61482